October 2, 2012 Development of a new Patient-Reported Outcome Measure for Major Depressive Disorder: Results of a Consortium-Based Approach
Drug Makers Join Efforts in Research Ten of the world’s largest pharmaceutical companies said on Wednesday that they would cooperate on research aimed at acceler
FDA, IMI, and Patient Advocates to Present at CDISC 2012 International Interchange Formal Launch of CFAST – Collaboration between C-Path and CDISC The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the launch of the Coaliti
Science foundation invaluable to Arizona The inclusion of C-Path in the Star’s centennial “100 Days of Science” series is a most welcome honor. What need
CDISC, C-Path and FDA Collaborate to Develop Data Standards to Streamline Path to New Therapies The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the signing of a part
April 6, 2012 Challenges and Recommendations Related to Assuring Quality Outcomes Data Collected via Electronic Platforms
April 6, 2012 Implementing New COA Instruments on Alternative Data Collection Modes: The Electronic Implementation Assessment
Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.
C-Path Initiative’s Work on Personalized Medicine Starts to Get Results The Critical path Institute (C-Path), the US Food and Drug Administration (FDA)-supported public-private initiative working to adv
